What is the efficacy of nonpharmacologic management for migraine headache?

Updated: Oct 21, 2019
  • Author: Jasvinder Chawla, MD, MBA; Chief Editor: Helmi L Lutsep, MD  more...
  • Print

Trials of nonpharmacologic management have produced average reduction in migraines of 40–50%, closely paralleling results obtained in trials of preventive drugs; however, the evidence base for nonpharmacologic and pharmacologic prevention remains limited. A 16-month randomized, placebo-controlled trial by Holryod et al found that the combination of beta-blocker therapy and behavioral management improved outcomes in patients with frequent migraines, while neither intervention was effective by itself. [88]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!